Psylink logo — Synthetic biology for science and humanity

Psylink

Synthetic biology for science and humanity

Founded 2020 Lithuania Lithuania 4 employees Pre-Seed Total: $501.52K

General Information

Company Name Psylink
Founded Year 2020
Location Lithuania Lithuania
Employees 4
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Psylink. To contact Psylink, visit psylink.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Psylink

We are developing a new class of targeted psychedelic agents to selectively intervene with serotonin receptors. Using synthetic biology, genome engineering tools we create well-known and new psychedelic derivatives used in preclinical and clinical research to eradicate most debilitating mental health disorders.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre-Seed 501.52K 4
FIRSTPICK, Coinvest Capital +2
29 Jul 2025

FAQ About Psylink

Synthetic biology for science and humanity
Psylink was founded in 2020.
Psylink is headquartered in Lithuania.
Psylink has approximately 4 employees.
Psylink has completed 1 funding round, raising a total of $501.52K. The latest funding stage is Pre-Seed.

Source: BounceWatch company record for Psylink, https://bouncewatch.com/company/psylink, updated 29 July 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes